Customized medication, accuracy medication, or theranostics is a clinical model that isolates individuals into various gatherings—with clinical choices, practices, intercessions as well as items being custom-made to the individual patient dependent on their anticipated reaction or danger of ailment. The terms customized medication, exactness medication, defined medication and P4 medication are utilized reciprocally to portray this idea however a few creators and associations utilize these articulations independently to show specific subtleties. While the fitting of treatment to patients goes back in any event to the hour of Hippocrates, the term has ascended in utilization as of late given the development of new analytic and informatics moves toward that give comprehension of the atomic premise of sickness, especially genomics. This gives an unmistakable proof base on which to separate (gathering) related patients. In customized medication, symptomatic testing is frequently utilized for choosing suitable and ideal treatments dependent on the setting of a patient's hereditary substance or other atomic or cell investigation. The utilization of hereditary data has assumed a significant job in specific parts of customized medication (for example pharmacogenomics), and the term was first authored with regards to hereditary qualities, however it has since widened to incorporate a wide range of personalization measures. With the end goal for doctors to know whether a transformation is associated with a specific illness, scientists frequently do an investigation called a "genome-wide affiliation study" (GWAS). A GWAS study will take a gander at one malady, and afterward succession the genome of numerous patients with that specific ailment to search for shared changes in the genome. Transformations that are resolved to be identified with an illness by a GWAS study would then be able to be utilized to analyze that sickness in future patients, by taking a gander at their genome succession to locate that equivalent change. The first GWAS, directed in 2005, examined patients with age-related macular degeneration (ARMD). It discovered two distinct transformations, each containing just a variety in just a single nucleotide (called single nucleotide polymorphisms, or SNPs), which were related with ARMD. GWAS considers like this have been extremely effective in distinguishing basic hereditary varieties related with sicknesses. Starting at mid 2014, more than 1,300 GWAS considers have been finished.

Top journals have been successfully publishing quality Research articles from many years and looking forward to framing up an eminent, outstanding issue with best quality research articles. This information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports.We request you to kindly submit and publish your paper in this best journal and get global acknowledgement.